Year archive

Profound Medical Corp. — 2025 filings

All 43 regulatory filings released by Profound Medical Corp. (PROF) in 2025, sourced directly from the official regulator.

43 Filings

2025 Period

2025 filings (43)

Filing	Released	Lang
News release - English.pdf Capital/Financing Update	2025-12-24	English
News release - English.pdf Capital/Financing Update	2025-12-23	English
News release - English.pdf Capital/Financing Update	2025-12-19	English
News release - English.pdf Regulatory Filings	2025-12-04	English
News release - English.pdf Regulatory Filings	2025-11-18	English
News release - English.pdf Regulatory Filings	2025-10-16	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings Q1 2025	2025-05-08	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-05-08	English
Other.pdf Interim / Quarterly Report Q1 2025	2025-05-08	English
Interim MD&A - English.pdf Interim / Quarterly Report Q1 2025	2025-05-08	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings Q2 2025	2025-05-08	English
News release - English.pdf Earnings Release Q1 2025	2025-05-08	English
Certificate re dissemination to shareholders.pdf Proxy Solicitation & Information Statement	2025-04-23	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-04-22	English
Other.pdf Regulatory Filings	2025-04-22	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-04-22	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-04-22	English
News release - English.pdf Report Publication Announcement	2025-04-17	English
Other.pdf Governance Information	2025-03-08	English
Other.pdf Regulatory Filings	2025-03-08	English
Material document(s).pdf Capital/Financing Update	2025-03-08	English
Annual report on form 10-K - English.pdf Annual Report FY 2024	2025-03-08	English
Other.pdf Governance Information	2025-03-08	English
Cover letter.pdf Report Publication Announcement	2025-03-08	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-08	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-08	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings FY 2024	2025-03-08	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings FY 2024	2025-03-08	English
Annual MD&A - English.pdf Regulatory Filings	2025-03-08	English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf Regulatory Filings	2025-03-08	English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf Regulatory Filings	2025-03-08	English
Interim financial statements/report – English.pdf Interim / Quarterly Report 9M 2024	2025-03-08	English
Interim MD&A - English.pdf Management Reports	2025-03-08	English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf Regulatory Filings	2025-03-08	English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf Regulatory Filings	2025-03-08	English
Interim MD&A - English.pdf Management Reports	2025-03-08	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2024	2025-03-08	English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf Regulatory Filings	2025-03-08	English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf Regulatory Filings	2025-03-08	English
Interim MD&A - English.pdf Management Reports	2025-03-08	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2024	2025-03-08	English
News release - English.pdf Regulatory Filings	2025-01-13	English
News release - English.pdf Earnings Release Q4 2024	2025-01-08	English